Peptide-Based Topical Serum Reduces Bruising by 73% After Injectable Cosmetic Procedures

A topical serum containing peptides targeting iron clearance, collagen stimulation, and antimicrobial activity reduced post-injection bruise intensity by 73% at day 2-3 compared to moisturizer alone.

Widgerow, Alan D et al.·Journal of drugs in dermatology : JDD·2020·Moderate Evidencehuman
RPEP-05199HumanModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
human
Evidence
Moderate Evidence
Sample
N=Not specified in abstract
Participants
Patients receiving cosmetic injectable procedures

What This Study Found

At day 2-3 post-injection, participants using the peptide-containing serum had 73% less bruise color intensity and 81% showed less bruising compared to the bland moisturizer control.

Key Numbers

Reduced bruising, swelling, and pain versus controls.

How They Did This

Human clinical study comparing a peptide-containing topical product (INhance Post-Injection Serum with TriHex Technology) versus bland moisturizer for post-injectable procedure recovery. Bruise color intensity measured at multiple time points.

Why This Research Matters

Bruising after cosmetic injections is a top patient concern that limits procedure frequency and satisfaction. A validated topical product that accelerates healing could significantly improve the injectable procedure experience.

The Bigger Picture

As demand for injectable cosmetic procedures continues to grow, reducing downtime and visible side effects becomes increasingly important. Peptide-based topical adjuncts represent a science-backed approach to faster recovery that could become standard post-procedure care.

What This Study Doesn't Tell Us

Industry-sponsored study (Alastin Skincare). Comparison was against bland moisturizer rather than an active comparator. Specific peptide concentrations and formulation details not fully disclosed. Relatively small study window.

Questions This Raises

  • ?Which specific peptides in the formulation are most responsible for the anti-bruising effect?
  • ?How does this product compare to arnica or other common post-procedure remedies?
  • ?Would the collagen and elastin stimulation provide measurable long-term skin benefits beyond bruise resolution?

Trust & Context

Key Stat:
73% less bruise color intensity at day 2-3 with peptide serum vs. moisturizer
Evidence Grade:
Human clinical study with measurable outcomes and statistical significance, though industry-sponsored with a bland moisturizer comparator.
Study Age:
Published in 2020. The product (TriHex Technology) has since gained wider clinical adoption.
Original Title:
Developing a Topical Adjunct to Injectable Procedures.
Published In:
Journal of drugs in dermatology : JDD, 19(4), 398-404 (2020)
Database ID:
RPEP-05199

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How do peptides help with bruise healing?

Specific peptides target the iron deposits left in tissue from broken blood vessels, stimulating macrophages to clear the residual iron faster, which is what creates the visible bruise discoloration.

Can this serum be used after any type of injection?

The product was designed as an adjunct to cosmetic injectable procedures including fillers, neurotoxins (like Botox), and skin-tightening treatments.

Read More on RethinkPeptides

Cite This Study

RPEP-05199·https://rethinkpeptides.com/research/RPEP-05199

APA

Widgerow, Alan D; Jacob, Carolyn; Palm, Melanie D; Garruto, John A; Bell, Michaela. (2020). Developing a Topical Adjunct to Injectable Procedures.. Journal of drugs in dermatology : JDD, 19(4), 398-404. https://doi.org/10.36849/JDD.2020.5016

MLA

Widgerow, Alan D, et al. "Developing a Topical Adjunct to Injectable Procedures.." Journal of drugs in dermatology : JDD, 2020. https://doi.org/10.36849/JDD.2020.5016

RethinkPeptides

RethinkPeptides Research Database. "Developing a Topical Adjunct to Injectable Procedures." RPEP-05199. Retrieved from https://rethinkpeptides.com/research/widgerow-2020-developing-a-topical-adjunct

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.